2025 first_quarter Filing
Q1Lobbying Activities
Shield laws; H.R. 685 Support and Value Expectant Moms and Babies Act; Chemical abortion drugs; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; Administration Personnel; Presidential Administration Actions
H.R. 699 No Taxpayer Funding for the U.N. Population Fund; S.250 Protecting Life in Foreign Assistance Act; Presidential Administration Actions